SCHEMBL23805790

SCHEMBL23805790

c1ccc(-n2c3ccccc3c3c4c5ccccc5n(-c5cccc6c5sc5ccccc56)c4ccc32)nc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.33
▸ ALOX5 P09917 1/20 0.32
▸ KRAS P01116 1/20 0.31
▸ POLB P06746 2/20 0.31
▸ EP300 Q09472 1/20 0.31
▸ KAT2B Q92831 1/20 0.31
▸ TSHR P16473 2/20 0.31
▸ HTT P42858 2/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ MIF P14174 1/20 0.30
▸ GABRA1 P14867 1/20 0.30
▸ GPR3 P46089 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ CASP1 P29466 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17246469 0.88 KMT2A (0.35) KMT2AKRASPOLBEP300KAT2B
SCHEMBL18086142 0.87 GPR3 (0.39) KMT2AALOX5SMN1; SMN2GPR3RAB9A
SCHEMBL17246379 0.85 KMT2A (0.31) KMT2ATSHRHTTSMN1; SMN2KDM4E
SCHEMBL21007230 0.83 ACHE (0.31) ALOX5ACHE
SCHEMBL21117208 0.83 PRKDC (0.35) ALOX5GPR3ALDH1A1
SCHEMBL16171206 0.82 ALOX5 (0.38) KMT2AALOX5SMN1; SMN2GPR3RAB9A
SCHEMBL21007579 0.81 CLK1 (0.32) ALOX5ACHE
SCHEMBL15804104 0.81 ATM (0.45) KMT2AALOX5POLBTSHRHSD17B10
SCHEMBL17246534 0.81 GPR3 (0.38) KMT2AALOX5POLBSMN1; SMN2GPR3
SCHEMBL17246471 0.81 KMT2A (0.36) KMT2APOLBEP300KAT2BHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702420-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-07-18 — — US disclosed
US-11702420-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-07-18 — — US disclosed
US-20210323968-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-10-21 — — US disclosed
US-11117897-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2021-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11117897-B2 Organic electroluminescent materials and devices ECI1, NDUFS3, NDUFV1 KMT2A 3445/4885ALOX5 1721/4885KRAS 3466/4885
US-11702420-B2 Organic electroluminescent materials and devices ECI1, NDUFS3, NDUFV1 KMT2A 3445/4885ALOX5 1721/4885KRAS 3466/4885
US-20210323968-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ECI1, NDUFS3, NDUFV1 KMT2A 3445/4885ALOX5 1721/4885KRAS 3466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback